
	Three Months Ended				Six Months Ended
(in millions)	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
Revenues by segment:
Healthcare	$	370.3	$	343.9	$	741.3	$	683.5
Other(1)	0.6		—		1.6		—
Total revenue by segment	$	370.9	$	343.9	$	742.9	$	683.5

Cost of goods sold by segment:
Healthcare	$	137.5	$	129.0	$	274.5	$	257.2
Other(1)	0.1		7.6		1.1		12.4
Total costs of goods sold by segment	$	137.6	$	136.6	$	275.6	$	269.6


Gross profit by segment:
Healthcare
Segment gross profit	$	232.8	$	214.9	$	466.9	$	426.3
Acquired asset amortization(1)(2)	(0.3)		(0.5)		(0.6)		(1.0)
Business transition and related costs(1)(3)	0.8		(6.8)		1.1		(7.1)
Acquisitions, integrations, divestitures, and related costs(1)(4)	—		(0.1)		—		(0.1)
Other(1)	—		(0.2)		(0.1)		(4.2)
Total gross profit by segment	$	233.3	$	207.3	$	467.3	$	413.9

(1) Management excludes certain revenues and expenses from segment gross profit. Management considers these excluded amounts to be non-recurring or non-operational and as such, are excluded from segment gross profit as this enables management to better understand operational results.

(2) Acquired asset amortization is a non-GAAP financial measure. These transactions represent amortization expense in connection with business or assets acquisitions associated with acquired intangible assets including, but not limited to customer relationships, intellectual property, trade names and non-competition agreements.

(3) Business transition and related costs are a non-GAAP financial measure. These transactions represent gains, losses, and other related costs associated with business transition plans. These items may include but are not limited to severance, relocation, consulting, leasehold exit costs, asset impairment, and other related costs to rationalize our operational footprint and optimize business results.

(4) Acquisitions, integrations, divestitures, and related costs are a non-GAAP financial measure. These transactions represent gains, losses, and other related costs associated with acquisitions, integrations, investments, divestitures, assets impairments, and in-process research and development.